Product NDC: | 0409-2265 |
Proprietary Name: | Desmopressin Acetate |
Non Proprietary Name: | Desmopressin Acetate |
Active Ingredient(s): | 4 ug/mL & nbsp; Desmopressin Acetate |
Administration Route(s): | INTRAVENOUS; SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-2265 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075220 |
Marketing Category: | ANDA |
Start Marketing Date: | 20101019 |
Package NDC: | 0409-2265-01 |
Package Description: | 10 AMPULE in 1 BOX (0409-2265-01) > 1 mL in 1 AMPULE |
NDC Code | 0409-2265-01 |
Proprietary Name | Desmopressin Acetate |
Package Description | 10 AMPULE in 1 BOX (0409-2265-01) > 1 mL in 1 AMPULE |
Product NDC | 0409-2265 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Desmopressin Acetate |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS; SUBCUTANEOUS |
Start Marketing Date | 20101019 |
Marketing Category Name | ANDA |
Labeler Name | Hospira, Inc. |
Substance Name | DESMOPRESSIN ACETATE |
Strength Number | 4 |
Strength Unit | ug/mL |
Pharmaceutical Classes | Factor VIII Activator [EPC],Increased Coagulation Factor VIII Activity [PE],Increased Coagulation Factor VIII Concentration [PE],Vasopressin Analog [EPC],Vasopressins [Chemical/Ingredient] |